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Assessment of telomere length (TL) in peripheral blood leukocytes is part of the diagnostic algorithm applied to
patients with acquired bone marrow failure syndromes (BMFSs) and dyskeratosis congenita (DKC). Monochrome
multiplex–quantitative polymerase chain reaction (MM–qPCR) and fluorescence in situ hybridization (flow-FISH)
are methodologies available for TL screening. Dependent on TL expressed in relation to percentiles of healthy con-
trols, further genetic testing for inheritedmutations in telomeremaintenance genes is recommended. However, the
correct threshold to trigger this genetic workup is still under debate. Here, we prospectively compared MM–qPCR
andflow-FISHregarding their capacity for accurate identificationofDKCpatients.All patients (n= 105) underwent
genetic testing by next-generation sequencing and in 16 patients, mutations in DKC-relevant genes were identified.
Whole leukocyte TL of patients measured by MM–qPCR was found to be moderately correlated with lymphocyte
TL measured by flow-FISH (r2 = 0.34; P < 0.0001). The sensitivity of both methods was high, but the specificity of
MM–qPCR (29%) was significantly lower compared with flow-FISH (58%). These results suggest that MM–qPCR
of peripheral blood cells is inferior to flow-FISH for clinical routine screening for suspected DKC in adult patients
with BMFS due to lower specificity and a higher rate of false-positive results.
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Introduction
Over the last decades, knowledge about telomere-
related pathologies has gained increasing impor-
tance in understanding pathophysiology of
hematological malignancies1 in general and in
hematopoietic stem cell disorders in particular.
This is mostly due to the fact that the hematopoietic
aThese authors contributed equally to this work.
system is a tissue with one of the highest rates of cell
turnover in the human body,2 which potentiates the
importance of intact telomere maintenance mech-
anisms for homeostasis of blood cell production.
Telomeres represent repetitive DNA sequences
and are located at the end of chromosomes. This
capping function protects chromosomes from
fusion, degradation, and activation of DNA damage
checkpoints.1,3 In most somatic cells, telomeres
shorten with each cell division due to the so-called
doi: 10.1111/nyas.14248
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Figure 1. Schematic image of telomere length distribution, age, and occurrence of telomeropathies. Typical telomere attri-
tion profile of patients with distinct manifestations of telomere diseases, such as Hoyeraal–Hreidarsson syndrome, dyskerato-
sis congenita, aplastic anemia, and pulmonary fibrosis. The gap between short and extremely short telomere lengths (in kb)
narrows with developing age (in years). Modified from Armanios, M. and E.H. Blackburn. 2012. Nat Rev Genet. 13: 693–704.
https://doi.org/10.1038/nrg3246. [Correction added on November 1, 2019, after online publication: Reproduction information of
Figure 1 was appended at the end of the figure legend.]
end-replication problem.4 Telomere shortening
thus limits the proliferative capacity in human
somatic cells by creating a barrier of replicative
senescence once a critically short telomere length
(TL) is reached.5
Telomerase is awidely conserved enzyme that has
the ability of replacing lost telomeric sequences.3
High cell turnover tissues, such as the hematopoi-
etic system, are particularly susceptible to defects in
telomere maintenance genes as, for example, genes
of the telomerase complex.6 Premature telomere
loss due to defects in telomerase or other telom-
ere maintenance–related genes limits the prolifera-
tion potential of cells, including stem cells, leading
to decreased tissue renewal capacity and premature
aging.7
Dyskeratosis congenita (DKC) was the first
inheritable disorder to be linked with impaired
telomere maintenance. Classical DKC patients are
characterized typically by early clinical manifesta-
tion during childhood and multiorgan involvement
leading to bone marrow failure (BMF), skin and
nail affection, and idiopathic pulmonary fibrosis.8
Mutations in a variety of telomere maintenance
genes, such as dyskerin pseudouridine synthase
1 (DKC1), regulator of telomere elongation
helicase 1 (RTEL1), TERF1-interacting nuclear
factor 2 (TINF2), conserved telomere mainte-
nance component 1 (CTC1), nucleolar protein
10 (NOP10), H/ACA ribonucleoprotein complex
subunit 2 (NHP2), WD repeat–containing protein
79 (WRAP53, also known as telomerase Cajal body
protein 1, TCAB1), telomerase reverse transcrip-
tase (TERT), and telomerase RNA component
(TERC), have been linked with the classical variant
of DKC.7–10 However, in approximately 40% of all
clinical DKC patients, no genetic aberration has yet
been identified, and, consequently, the suspected
diagnosis needs to be established primarily on the
basis of the patients’ clinical presentation and their
family history and pedigree assesment.7–10
Nowadays, there is a growing body of evidence
pointing to a significant incidence of late-onset
hereditary telomere maintenance disorders first
manifesting themselves in adult patients. These
so-called “cryptic” DKC cases often present with
mono- or oligosymptomatic organ manifestations,
such as interstitial lung fibrosis, aplastic anemia,8,10
or idiopathic liver cirrhosis. Diagnosis of cryptic
adult DKC is especially challenging as the pattern
of affected organs and disease penetrance may
vary extremely among individuals.11,12 In addi-
tion, missed diagnosis occurs because physicians
typically do not expect the first manifestations of
an inheritable disorder in young or middle-aged
adults. Yet, the correct diagnosis is crucial for
further patient management: correctly identified
patients can undergo telomerase-activating therapy
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using androgen derivatives13 or need adapted con-
ditioning protocols for allogeneic stem cell trans-
plantation to reduce the high mortality observed
in DKC patients.14,15 In addition, proper genetic
counseling of affected families, including suitable
donor selection in cases of available family donors
for allogeneic stem cell transplantation, is crucial.
Accelerated shortening of TL represents the func-
tional readout of directly or indirectly altered telom-
erase function in telomeropathies. Consequently,
TL measurement in peripheral blood leukocytes
(PBLs) is recommended as a screening tool to iden-
tify telomeropathies.6,16,17 However, due to the nat-
ural age–dependent decline of TL in normal cells,
the diagnostic window between shortened TL—
in relation to age-adjusted controls—and critically
and functionally short telomeres (below the 1%
percentile of normal controls), which reflect an
underlying telomere disease, narrows with advanc-
ing age18 (Fig. 1).
The actual diagnostic algorithm for germline
telomeropathies includes the assessment of TL
from PBLs of all patients with suspected BMF
using fluorescence in situ hybridization (flow-
FISH) or monochrome multiplex–quantitative
polymerase chain reaction (MM–qPCR).10 Flow-
FISH provides the advantage of measuring TL of
granulocytes and lymphocytes separately within
the same sample.19 If a patient’s mean telomere
content is either below the first percentile of a
normal control cohort or alternatively between
the 1st and 10th percentiles and typical clinical
symptoms or the family history is suggestive of a
telomeropathy, further genetic testing for inher-
ited mutations in telomere maintenance genes is
recommended.10
In this study, we aimed to compare the sen-
sitivity and specificity of MM–qPCR and flow-




Peripheral blood (PB) samples of 105 patients
from different academic centers in Germany, Aus-
tria, and Switzerland were analyzed. After written
informed consent was obtained, all samples were
taken according to the approval by the local ethics
committee (EK206/09). Patient inclusion criteria
were based on the clinical suspicion for DKC or
telomeropathy of the treating physician and/or
the recommendations of the German Society of
Hematology and Oncology (DGHO) published
via Onkopedia (www.onkopedia.de). Samples were
analyzed with flow-FISH and MM–qPCR, and, if
deemed critically short, followed up for underlying
mutations by next-generation sequencing (NGS).
DNA extraction
DNA from the mononuclear cell (MNC) frac-
tion in the PB samples was extracted for MM–
qPCR and NGS using the DNeasy R© Blood &
Tissue Kit (Qiagen, Hilden, Germany) according
to the manufacturer’s instructions. DNA was fur-
ther cleaned with DNA Clean & Concentrator R©-
5 kit (Zymo Research, Irvine, CA). For NGS,
250 ng genomic DNA was used per reaction. For
MM–qPCR, 4.98 ng genomic DNA was used per
reaction.
Targeted amplicon sequencing
NGS (MiSeq R©, Illumina, Germany) was done as
previously described.20 Library preparation was
done using the TruSeq R© Custom Amplicon kit
(Illumina). Genetic variants/heterozygous muta-
tions in telomere maintenance genes were screened
using a self-designed panel containing the entire
coding sequences for CTC1, DKC1, NHP2, NOP10,
RTEL1, TERC, TERT, TCAB1, USB1, and exon 6 of
TINF2.20,21
Flow-FISH
Vital sterile frozen MNC from PB was used
for the flow-FISH analysis of TL, as previously
described.22–26 Briefly, samples were prepared for
cell denaturation and mixed with an FITC-labeled
telomere-specific (CCCTAA)3-peptide nucleic acid
FISH probe (Eurogentec, Liège, Belgium) for DNA
hybridization followed by DNA counterstaining
with LDS 751 (Sigma). Bovine thymocytes were
used as internal controls. An FC 500 flow cytometer
(Becton Dickinson) was used for data acquisition.
All measurements were carried out single-blinded
in triplicates. TL of bovine thymocytes was deter-
mined by western blot (19.515 kb) and was used
to convert the TL of granulocytes and lympho-
cytes into kb. Healthy controls (n = 365) were
used for age adaptation of TL for flow-FISH, as
described previously.22–26 A separate cohort of 89
healthy controls was used for age adaption of TL
for MM–qPCR.27,28
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Table 1. Characteristics of the Aachen Telomeropathie
Registry patients
Aachen Telomeropathie Registry (ATR)
Mean age ATR (in years) 45 ± 21
Gender, male:female (n) 57:48




Family members of and known DKC 17
PNH 12
Others (e.g., IPF) 10
Blood counts
Leukocytes/nL (range) 4.4 (0.6–21.7)
Hemoglobin g/dL (± SD) 10.5 ± 2.3
Platelets/nL (range) 78 (1–471)





TL analysis by MM–qPCR followed the original
protocol described byCawthon et al.29,30 Essentially,
primer pairs used for telomere amplification were
telg 5′–ACACTAAGGTTTGGGTTTGGGTTTGG
GTTTGGGTTAGTGT–3′ and telc 5′–TGTTAGG
TATCCCTATCCCTATCCCTATCCCTATCCCTA
ACA–3′, while signal acquisition was at 74 °C.
For reference, a signal for human beta-globin was
acquired at 88 °C using the primers hbgu 5′–CGGC
GGCGGGCGGCCGGGGCTGGGCGGCTTCAT
CCACGTTCACCTTG–3′ and hbgd 5′–GCCCGG
CCCGCCGCGCCCGTCCCGCCGGAGGAGAA
GTCTGCCGTT–3′, as previously described.23,27,28
All measurements were carried out as single-
blinded in triplicates. Leukocytes from healthy
subjects (n = 105) were used for age adaptation
of TL, which is given in T/S ratios. A T/S ratio is
calculated by dividing the number of copies of the
telomere template (T) by the beta-globin template
(S). For Bland–Altman analysis, T/S ratios were
converted into kb using four cell lines with known
TL (Fig. S1, online only).
Statistical analysis
GraphPad Prism 5.0 (GraphPad, San Diego, CA)
was used for statistical analysis. Statistical analysis
was carried out using Fisher-(exact)-test and Pear-
son correlation. P values < 0.05 were considered
Figure 2. Correlation between MM–qPCR (T/S ratio) and
lymphocyte flow-FISH (kb). (A) Linear regression plots of
telomere lengths (TLs)measured byMM–qPCR or lymphocyte
flow-FISH for all ATR patients. Solid line depicts data’s best fit
(r2 = 0.34; P < 0.0001; n = 105). (B) TLs for DKC patients.
Solid line depicts data’s best fit (r2 = 0.29;P= 0.03; n= 16). (C)
Bland–Altman plot for agreement analysis of flow-FISH (kb)
and MM–qPCR (T/S ratio) of the TLs of all ATR patients. Bias
± 2 SD = 0.16, LoA ranging from 0.02 to 0.31.
as statistically significant. The Tel to percentile
value was calculated based on the difference (kb or
T/S ratio) of the measured TL of the patient to the
respective age-adapted 1% or 5% percentile.
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Figure 3. Telomere length according to age in ATR patients measured by (A) MM–qPCR (T/S ratio), (B) lymphocyte flow-FISH
in kb, and (C) granulocyte flow-FISH in kb. Percentile cutoffs to detect patients with extremely short telomere were calculated




The patient population studied here represents an
adult population screened for late-onset hereditary
telomeropathies (age 45 ± 12 years; mean ± SD).
The initial diagnoses made by the treating physi-
cian were aplastic anemia in 41% (43/105), unex-
plained cytopenia in 13% (14/105), myelodysplastic
syndrome in 9% (9/105), clinically suspected DKC
or DKC family member of a patient with DKC in
16% (17/105), paroxysmal nocturnal hemoglobin-
uria in 11% (12/105), and other diseases (for exam-
ple, interstitial lung disease in 10% (10/105) of all
patients). NGS was carried out in all 105 patients
and led to the identification of 16 patients with
mutations in the genes TERC (n= 6), TERT (n= 7),
DKC1 (n = 1), and RTEL1 (n = 2) (see Table 1 and
Table S1, online only).
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Correlation between flow-FISH
and MM–qPCR
Direct comparison of flow-FISH for lymphocytes
with MM–qPCR led to a modest but highly signif-
icant correlation between the two methodologies
(r2 = 0.34; n= 105; P< 0.0001; Fig. 2A) contrasting
with other studies, where weaker correlations were
reported.31 When only molecularly proven DKC
patients were considered, the correlation between
the methods was found to be lower (r2 = 0.29;
n = 16; P = 0.03; Fig. 2B), in contrast with other
studies, where a stronger correlation for DKC
patients was reported.32 Overall, the range of corre-
lation values was low in line with previous studies
showing similar correlations between flow-FISH
and MM–qPCR.31–35
Bland–Altman analysis confirmed that the over-
all agreement between flow-FISH and MM–qPCR
was poor. Mean ratios and limits of agreement
(LoA) between flow-FISH and MM–qPCR were
moderate, with an average of 0.28 kb (LoA, 3.71 to
−3.42 kb; Fig. 2C), as well as for DKC patients, with
a mean ratio of –0.32 (LoA, 0.90 to –1.65 kb; Fig. 2).
Direct comparison of flow-FISH and
MM–qPCR to detect DKC patients
To directly compare both techniques for their valid-
ity to trigger further genetic workup, we used the
10th, 5th, and 1st percentiles as a trigger for genetic
testing (Fig. 3A–C), as percentiles are the estab-
lished way to screen for telomeropathies. Applying
NGS, 16 patients with known DKC-causing muta-
tions were identified and used to analyze the
sensitivity, specificity, positive predictive value,
and rate of false-positive values for flow-FISH and
MM–qPCR. Since flow-FISH provides results for
TL of lymphocytes and granulocytes separately,
both subpopulations—lymphocyte and granulo-
cyte flow-FISH—were compared separately with
MM–qPCR.
Sensitivity and specificity of flow-FISH
and MM–qPCR
Flow-FISH displayed a sensitivity of 75% with TL
below the 1st percentile, increasing to 88% using
the 5th or 10th percentile, respectively. For MM–
qPCR, the sensitivity was 69% using the 1st per-
centile, increasing to 94% using the 5th or 10th
percentile, respectively. Sensitivity between lym-
phocyte flow-FISH and MM–qPCR did not differ
significantly (Fig. 4A). Similar results were ob-
served for granulocyte flow-FISH compared with
MM–qPCR (Fig. S3A, online only).
Next, we analyzed the specificity of lympho-
cyte flow-FISH and MM–qPCR. We observed a
decrease in specificity of the lymphocyte flow-FISH
from 84% to 69% and 58% using either the 1st,
5th, or 10th percentile. In comparison, MM–qPCR
showed a more pronounced decline of specificity
from 78% to 46% to 29% using either 1st, 5th, or
10th percentile, with statistically significant results
only for the 10th percentile (P = 0.01, Fig. 4B).
Similar results were obtained for the comparison
of the granulocyte flow-FISH with the MM–qPCR.
For the granulocyte flow-FISH, specificity was 72%,
61%, and 56% for the 1st, 5th, and 10th percentiles,
respectively (Fig. S3B, online only). Specificity of
granulocyte flow-FISH for the 10th percentile was
significantly higher compared with the MM–qPCR
(P = 0.02).
False-positive/-negative rate and
positive/negative predictive value of
flow-FISH and MM-QPCR
We then analyzed the rate of false-positive values.
Lymphocyte flow-FISH displayed a rate of false
positivity of 13% with TL below the 1st percentile,
increasing to 27% and 35% using the 5th and 10th
percentiles, respectively. In comparison, the rate of
false-positive values achieved by MM–qPCR was
19% using the 1st percentile, increasing to 46% and
60% using the 5th or 10th percentile, respectively.
Direct comparison did not reveal a statistical dif-
ference for the 1st percentile, but yet a trend for the
5th percentile (P = 0.06). The rate of false-positive
values for the 10th percentile was 60% for MM–
qPCR and significantly higher compared with lym-
phocyte flow-FISH with 35% (P = 0.03, Fig. 4C).
A similar trend was found comparing the granu-
locyte flow-FISH with MM–qPCR.
The rate of false-positive values for the granulo-
cyte flow-FISH increased from 24% using the 1st
percentile to 33% and 37% for the 5th and 10th
percentiles, respectively. In the 10th percentile, a
statistical trend (P = 0.054) favoring the granu-
locyte flow-FISH compared with MM–qPCR was
observed (Fig. S3C, online only).
In the next step, we analyzed the positive predic-
tive value. We observed a decrease in lymphocyte
flow-FISH from 46% to 33% and 27% using the 1st,
5th, or 10th percentile, respectively. MM–qPCR
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Figure 4. Patient detection rates of MM–qPCR and lymphocyte flow-FISH according to the 1st, 5th, and 10th percentile cutoffs.
(A) Sensitivity. (B) Specificity. (C) False-positive values. (D) Positive predictive value. Black bars represent the lymphocyte flow-
FISH and light gray bars represent the MM–qPCR.
showed a more pronounced decline from 35%
to 24% to 19% using 1st, 5th, or 10th percentile,
respectively (Fig. 4D). Comparison of the positive
predictive values did not differ significantly.
Similar results were observed for the granulocyte
flow-FISH. Here, we observed a positive predictive
value of 35%, 24%, and 19% for the 1st, 5th, or 10th
percentile, respectively (Fig. S3D, online only).
Finally, analysis of the negative predictive value
and false negativity did not reveal any significant
differences for the MM–qPCR group and granulo-
cyte flow-FISH (Fig. S4A and B and Table S2, online
only).
Combination of lymphocyte flow-FISH with
MM–qPCR or granulocyte flow-FISH
Based on our previous results, lymphocyte flow-
FISH resulted in higher specificity and lower
rates of false-positive values compared with MM–
qPCR or granulocyte flow-FISH. Here, we analyzed
whether a combination of lymphocyte flow-FISH
with MM–qPCR or granulocyte flow-FISH can fur-
ther improve the sensitivity, specificity, rate of false-
positive values, or positive predictive value, espe-
cially when applied for the 5th or 10th percentile.
We combined (1) the threshold of the 1% per-
centile of lymphocyte flow-FISH with the 1%
percentile of the MM–qPCR, (2) the threshold
of 5% of lymphocyte flow-FISH with the 1% per-
centile of the MM–qPCR, and (3) 5% threshold of
lymphocyte flow-FISH with the 1% percentile of
the granulocyte flow-FISH. Of note, all combina-
tions resulted in a nonsignificant lower sensitivity
as lymphocyte flow-FISH alone (Fig. 5A and
B). By contrast, all combinations showed a non-
significant trend (all P values ≤ 0.1) to higher
specificity compared with lymphocyte flow-FISH
alone (Fig. 5B).
Analyzing the rate of false-positive values, the
combination of the 5% percentile cutoff for the
lymphocyte flow-FISH combined with the 1%
percentile of the MM–qPCR rates of false-positive
values (27% versus 12%, P = 0.01, Fig. 5C) was
significantly lower compared with lymphocyte
flow-FISH alone. A similar trend was found com-
bining lymphocyte and granulocyte flow-FISH
(27% versus 16%, P = 0.14, Fig. 5C).
Finally, focusing on the positive predictive val-
ues, we observed a nonsignificant tendency to
higher values in all combination groups compared
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Figure 5. Different cutoffs of lymphocyte flow-FISH combined with MM–qPCR or granulocyte low-FISH. (A) Graphical depic-
tion of different combinations. (B) Sensitivity. (C) Specificity. (D) False-positive values. (E) Positive predictive values. The cutoff
of the 1% percentile of lymphocyte flow-FISH with the 1% percentile of the MM–qPCR, 5% of lymphocyte flow-FISH combined
with the 1%percentile of theMM–qPCR, and the 5% threshold of lymphocyte flow-FISHwith the 1%percentile of the granulocyte
flow-FISH was used.
with lymphocyte flow-FISH (Fig. 5D and Table S3,
online only).
Discussion
Valid screening tools to reliably identify
patients with a high likelihood of an underlying
telomeropathy are urgently needed, particularly
for the diagnostic workup of adult and pediatric
patients with newly diagnosed BMF syndromes.
Few studies have thoroughly compared and vali-
dated the different available methods for telomere
assessment within clinical routine.31,32 Previously
published studies were either limited by the analysis
of cohorts of family members of DKC patients or
compared both techniques without testing the
application for TL screening of these techniques
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within a prespecified diagnostic algorithm.31,32
Hence, our study introduces a prospective
comparison of these two potentially applicable
methods to the routine TL assessment on the
largest cohort of patients with clinical suspicion of
telomere disease so far.
We confirm previous observations showing
that the two mostly used high-throughput TL
assays—flow-FISH and MM–qPCR—do not cor-
relate constantly in their output,10,32 as several
factors contribute to the difficulty in the reliable
reproducibility of telomere measurements.36–38
Briefly, automated flow-FISH is considered the
method of choice for the clinical routine setting
of DKC screening as the main advantages of the
flow-FISH technique are its high precision, repro-
ducibility, and sensitivity.19 In addition, flow-FISH
provides telomere distribution across different
leukocyte subsets. Main disadvantages are the high
effort and quality control requirements for trans-
port, processing, and analyses of the samples,39 and
prerequisite of a viable cell population.
By contrast, MM–qPCR requires only small
amounts of DNA (i.e., it is not dependent on viable
cells) and moderate method-related effort, exper-
tise, and diligence.29,30 Main disadvantages of the
technique are the fact that high-quality DNA is
needed and MM–qPCR does not provide telom-
ere distribution within different cellular subsets.
Instead, results typically correspond to the TL aver-
age in all analyzed cells. This can be misleading
as, for example, specific hematopoietic subpopula-
tions can be affected to different degrees by underly-
ing acquired disease entities. As such, lymphocytes
are mostly clonal in patients with chronic lympho-
cytic leukemia, whereas granulocytes are nonclonal.
In noninheritable disorders, the latter can lead to
contamination by nondisease-affected cells, namely,
nonclonal versus clonal cells, and misinterpretation
of results.
Therefore, no optimal screening method for
inherited telomere maintenance disorders, such as
DKC, has been clearly identified until now. In our
current analysis, however, we found that flow-FISH
of lymphocytes so far is the most accurate method
to screen for DKC. Our findings were in line with
previous studies showing the advantage of lympho-
cyte flow-FISH over other techniques.18,40 As long
as the 1% percentile was used to trigger further
genetic workup, both flow-FISH and MM–qPCR
showed similar sensitivity and specificity. However,
by increasing the threshold to 5th or the recom-
mended 10% percentile, flow-FISH of the lym-
phocyte subpopulation demonstrated significantly
higher specificity and lower rates of false-positive
results compared with MM–qPCR. Hence, flow-
FISH, when used to screen for suspected telom-
eropathy might be a fast, reliable tool, even sparing
resources (e.g., less genetic testing) compared with
MM–qPCR.
In addition, while previous data led to the recom-
mendation of a 10% threshold for further genetic
workup, our data illustrate that a 5% threshold leads
to equal performance.10,41
The question whether an absolute TL threshold
of, for example, 6.5 kb might potentially be more
suitable to reliably identify DKC patients, partic-
ularly at an older age, warrants further validation.
Interestingly, a combination of lymphocyte flow-
FISH andMM–qPCR or granulocyte flow-FISH did
not result in an increased sensitivity or specificity,
but in a slightly reduced rate of false-positive values.
One limitation of our study is that the rate of
false-positive results might be lower since our NGS
screening is not covering rare or unknown genetic
DKC–causingmutations.However, a previous study
using whole-exome sequencing showed a relevant
cluster of mutated genes in BMF patients covered
by our NGS panel.
One explanation for our observation of the sig-
nificant decrease of specificity and higher false-
positive rates for MM–qPCR is the fact that MM–
qPCR TL analysis was performed on the whole
MNC fraction, including both the lymphoid and
myeloid populations. Other factors, like DNA qual-
ity or intrinsic characteristics of MM–qPCR, might
play an additional role explaining the observed dif-
ferences with flow-FISH.
Clinically, a correct TL assessment is of utmost
importance for affected patients and their fami-
lies and has immediate clinical consequences.14,42
First, prematurely shortened telomeres repre-
sent the functional readout of impaired telomere
maintenance.2 Second, NGS screening for relevant
DKC mutations reveals various polymorphisms.43
Identification of true mutations is frequently dif-
ficult since the actual capacity of bioinformatics
tools to predict the functional role of a muta-
tion/polymorphism is limited.44 Our data suggest
that MM–qPCR-based TL between 1% and 10%
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percentile should not be used as a functional
support for a possible disease-causing mutation.
Even for lymphocyte (and granulocyte) flow-FISH,
careful interpretation is of importance, especially
in patients in whom TL ranges between the 5% and
10% percentiles.
Special attention is warranted in cases of clinical
suspicion of typical DKC or overt DKC symptoms
without detectable mutations, representing up to
30–40% of all pediatric/adolescent patients.8 Here,
the assessment of TL is clearly recommended to
support the diagnosis of DKC, representing a func-
tional disease-defining marker.
In summary, we conclude that MM–qPCR is well
suitable and satisfactory for TL analysis in research
projects and retrospective analysis of large cohorts
of DNA samples. In clinical routine settings, flow-
FISH is superior over MM–qPCR and should be
recommended for prospective screening of DKC
patients based on TL assessment.
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